Bottle Label 4 mg (71610 0776 30)
Tizanidine Tablet
Product Images NDC 71610-776
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71610-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure-1.jpg (Figure 1)
The given text appears to be a description of a figure titled "Mean Tizanidine Concentration vs. Time Profiles For Tizanidine Tablets and Capsules (2 x 4 mg) Under Fasted and Fed Conditions". The figure likely presents data on the average concentration of Tizanidine over time for both tablets and capsules of Tizanidine (at a dosage of 2 x 4 mg) under two different conditions: fasted and fed. The figure may provide insights into how the concentration of Tizanidine varies over time based on the type of dosage form and the feeding condition.*
Figure-2.jpg (Figure 2)
Figure-3.jpg (Figure 3)
Chemical-structure (Tizanidine Imtb 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
